Also, fluphenazine-treated tumors showed enhanced iron deficiency, apoptosis and inhibition of proliferation compared with fluphenazine-treated KLF14-silenced tumors (Fig. 9K and Supplementary Fig. 8D-F). Here, KLF14 is linked to Iron deficiency anemia.